Company page

Cansino Biologics, Inc. Class A

Cansino Biologics, Inc. Class A is a publicly traded company on the 6ix platform, with a market capitalization of approximately 1.22 billion USD. The company operates in the biotechnology sector in China, focusing on developing innovative vaccines and biologics. As a key player in the industry, Cansino aims to address global health challenges through its advanced research and development efforts.